MedPharm Ltd

#ICYMI... We recently announced that MedPharm and Tergus have joined forces to establish the best-in-class end-to-end CDMO specializing in topical and transepithelial drug products. Read the full announcement or reach to us today for more information: https://lnkd.in/ee-AK72G

🎉 Exciting news from our valued sponsors! Congratulations to MedPharm Ltd and Tergus Pharma, two leading CDMO organizations, on their merger. 👉 Check out the press release here: https://lnkd.in/ee-AK72G

MedPharm Ltd, an Ampersand Capital Partners portfolio company, has merged with Tergus Pharma. Operating under the MedPharm name, the newly combined company forms a leading topical and transdermal CDMO providing a full suite of drug development and manufacturing services. https://lnkd.in/ev3XqJCN

MedPharm is excited to announce that we are joining forces with Tergus Pharma to create the best-in-class end-to-end topical and transepithelial CDMO. Michael Kane has been appointed CEO of the merged company, which will operate under the MedPharm name. Michael previously served as the CEO of Tergus. MedPharm will continue delivering the gold standard in topical development to pharmaceutical developers around the globe, from pre-clinical R&D to Phase II manufacturing, including our industry-leading in vitro testing services. This merger adds full commercial production capabilities to MedPharm’s portfolio of services, including high-potency and hormone-based drugs and comprehensive serialization. With locations in the U.K. and the U.S., the expanded end-to-end capabilities and continued commitment to innovation and research uniquely position MedPharm as the premier CDMO focused on topical and transepithelial drug products. Click here to learn more: https://hubs.la/Q02FB3yc0

MedSpray® is a patented aerosol formulation technology, known as a “patch-in-a-can,” developed by our experts for a range of applications. When combined with your API, the MedSpray® technology allows for a safer, more effective, and superior finished drug product. Visit our website to learn more about the advantages of MedSpray® today: https://lnkd.in/ebCEViDw #innovation #drugdevelopment #technology #respiratory

Bio International is in full swing!! Reach out to us through the platform or our website to catch up with Scott and Evan this week.

Only one more week until our team heads to Bio International! Scott Klepfer and Evan Andrews will be in San Diego June 3rd-6th to catch up with everyone. If you're interested in meeting with the team to discuss how MedPharm can support your ongoing programs, message us through the partnering platform or our website >> https://lnkd.in/eCkSm2e7 Biotechnology Innovation Organization #BIO2024

Presenting our wound model at SID

Happening today!! If you're at the Society for Investigative Dermatology Annual Meeting this week, be sure to visit Jon Volmer at this afternoon's poster presentation. Learn more on our website: https://lnkd.in/erse2h49

Next week, MedPharm's CSO, Jon Lenn, will present at the FDA's FY24 Generic Drug Science and Research Initiatives Public Workshop. Jon will present on the chemical stability of benzoyl peroxide and the potential formation of benzene in topical products. This annual workshop is free and open to the public. It is an opportunity to share the latest updates on science and research initiatives in the generic drug space and allows the public to contribute insights and perspectives on these initiatives. Read more about the workshop today: https://lnkd.in/erptEA9k FDA #FDA #generics